SWAV stock forecast
Our latest prediction for Shockwave Medical, Inc.'s stock price was made on the Aug. 21, 2020 when the stock price was at 59.06$.
In the short term (2weeks), SWAV's stock price should underperform the market by -1.70%. During that period the price should oscillate between -9.80% and +7.49%.
In the medium term (3months), SWAV's stock price should underperform the market by -5.76%. During that period the price should oscillate between -32.97% and +18.65%.Get email alerts
Create a solid portfolio with SWAV
About Shockwave Medical, Inc.
Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
At the moment the company generates 51M USD in revenues.
On its last earning announcement, the company reported a loss of -2.04$ per share.
The book value per share is 4.26$
Three months stock forecastAug. 21, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|